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Abstract
Cortical development depends on the active integration of cell autonomous and extrinsic cues, but
the coordination of these processes is poorly understood. Here, we show that the apical complex
protein Pals1 and Pten have opposing roles in localizing the Igf1R to the apical, ventricular
domain of cerebral cortical progenitor cells. We found that the cerebrospinal fluid (CSF), which
contacts this apical domain, has an age-dependent effect on proliferation, much of which is
attributable to Igf2, but that CSF contains other signaling activities as well. CSF samples from
patients with glioblastoma multiforme show elevated Igf2 and stimulate stem cell proliferation in
an Igf2-dependent manner. Together, our findings demonstrate that the apical complex couples
intrinsic and extrinsic signaling, enabling progenitors to sense and respond appropriately to
diffusible CSF-borne signals distributed widely throughout the brain. The temporal control of CSF
composition may have critical relevance to normal development and neuropathological conditions.
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Neural development involves a dynamic interplay between cell autonomous and diffusible
extracellular signals that regulate symmetric and asymmetric division of progenitor cells
(Johansson et al., 2010). In mammalian neural progenitors, homologues of C. elegans and
Drosophila polarity proteins, including Par3 (Partitioning Defective Protein 3) and Pals1
(Protein Associated with Lin 7), assemble as apical complexes that play essential roles in
regulating self-renewal and cell fate (Margolis and Borg, 2005). The unequal distribution of
apical surface components during mitosis is a key determinant of daughter cell fate in C.
elegans and Drosophila (Fishell and Kriegstein, 2003; Kemphues, 2000; Wodarz, 2005).
Recently, mammalian Par3 was shown to promote asymmetric cell division by specifying
differential Notch signaling in radial glial daughter cells (Bultje et al., 2009), suggesting that
the inheritance of the apical complex guides progenitor responses to proliferative signals as
well.
Secreted signals can act at a distance to guide decisions governing progenitor proliferation
and cell fate (Johansson et al., 2010), but little is known of how secreted signals interact
with cell-autonomous ones. Insulin-like growth factor 1 (Igf1) promotes progenitor
proliferation (Hodge et al., 2004; Popken et al., 2004). Insulin/Igf1 signaling is regulated by
E-catenin in keratinocytes (Vasioukhin et al., 2001) and β-catenin in oligodendrocyte
progenitors (Ye et al., 2010), suggesting that cell polarity proteins govern cellular responses
to extrinsic cues.
Direct interactions between Par3 and Pten (Phosphatase and Tensin homolog) (Feng et al.,
2008; Pinal et al., 2006; von Stein et al., 2005; Wu et al., 2007) suggest that the apical
complex interacts with growth factor signaling pathways. Indeed, disrupting the apical
complex via Pals1 leads to attenuated pS6 signaling, premature cell cycle exit, and rapid cell
death, resulting in the absence of nearly the entire cerebral cortex (Kim et al., 2010). In turn,
Pals1-deficiency can be partially rescued by concomitant activation of mTOR (Mammalian
Target of Rapamycin) (Kim et al., 2010), a downstream effector of growth factor signaling.
Growth factor signaling, in particular via the type 1 Igf receptor (Igf1R), mediates powerful,
age-dependent effects on the development and maintenance of many organ systems
including the brain through the regulation of progenitor cell division (Baker et al., 1993;
Hodge et al., 2004; Liu et al., 2009; Popken et al., 2004; Randhawa and Cohen, 2005).
Nevertheless, the mechanisms coordinating the availability of Igf ligands to cortical
progenitor cells have remained unclear.
Though vascular sources of secreted proliferative signals are well characterized (Palmer et
al., 2000; Shen et al., 2004; Shen et al., 2008; Tavazoie et al., 2008), the apical surfaces of
early cortical precursors and their primary cilia do not approximate blood vessels but instead
directly contact the cerebrospinal fluid (CSF) (Fuchs and Schwark, 2004; Kim et al., 2010),
suggesting that secreted factors may interact with progenitor cells at this interface. The CSF
proteome shows a complex and dynamic pattern of protein expression (Dziegielewska et al.,
1981; Parada et al., 2005; Zappaterra et al., 2007), suggesting important roles beyond
provision of a fluid cushion for the central nervous system and maintenance of extracellular
ionic balance. The CSF has recently been implicated in carrying secreted proteins in several
contexts, including Fgf2 to midbrain progenitors (Martin et al., 2006), Sonic hedgehog to
cerebellar progenitors (Huang et al., 2010), and Slit guidance of neuroblasts in adult brain
(Sawamoto et al., 2006). Regulation of cerebral cortical progenitor cells by growth factors
distributed in the lateral ventricular CSF would provide potentially global control over
cerebral cortical neurogenesis, but this hypothesis has not been examined.
Lehtinen et al. Page 2













Here we show that the apical complex couples autonomous regulation of progenitor
proliferation to CSF-borne signals in the developing cerebral cortex. Pals1 and Pten interact
genetically to regulate cerebral cortical size and progenitor proliferation, and have opposing
roles in localizing the Igf1R to the apical domain of cortical progenitors. Apically localized
Igf1Rs respond to CSF-borne Igf ligands, particularly Igf2, and CSF regulates cortical
progenitor proliferation and neural stem cell survival in an Igf2-dependent fashion. Finally,
CSF Igf2 concentration is elevated in patients with malignant glioblastoma, suggesting that
CSF proteins may regulate CNS tumorigenesis. Our findings suggest that the apical complex
couples autonomous and extrinsic signaling in cerebral cortical progenitors, enabling these
cells to respond appropriately to diffusible CSF-borne signals that regulate cortical neural
stem cells during development and disease.
Results
Genetic interactions of Pals1 and Pten at the apical surface region
Since Pals1 loss disrupts growth factor signaling and cortical development (Kim et al.,
2010), we looked for potential interactions of Pals1 with other regulators of growth factor
signaling and found genetic interactions between Pals1 and Pten (Groszer et al., 2001).
Cerebral cortex-specific deletion of Pals1 was achieved by crossing mice with a conditional
Pals1 allele (Pals1loxP/loxP) (Kim et al., 2010) with mice carrying Emx1-promoter-driven
Cre recombinase (Emx1Cre+/−) (Gorski et al., 2002). Pals1loxP/loxP/Emx1Cre+/− mice
lacked nearly the entire cortical structure due to premature cell cycle exit and cell death
(Kim et al., 2010), with heterozygotes having an intermediate phenotype (Figure 1A). In
contrast, Pten deficiency, obtained by crossing PtenloxP/loxP mice (Groszer et al., 2001) with
either Emx1Cre+/− or NestinCre+/− mice, resulted in cortical hyperplasia arising from
excessive and extended proliferation of apical progenitors (Figure 1A, Figure S1A-S1E)
(Groszer et al., 2001). While the broadest groupings of cells were preserved in Pten mutants,
the cortical plate was disorganized across its entire radial extent (Figure S1A-S1C). No
phenotypic abnormalities were observed in either heterozygous PtenloxP/+/NestinCre+/−
mice or in PtenloxP/loxP/NestinCre−/− littermate controls (Figure S1A and data not shown).
Conditional deletion of Pten in the Pals1loxP/+/Emx1Cre+/− mice resulted in an almost
normal cortical size (Figure 1A). Histological analyses of Pals1loxP/+/Emx1Cre+/− mice, or
PtenloxP/+/Pals1loxP/+/Emx1Cre+/− mice, revealed a severely disrupted laminar organization
of the dorso-medial cortex (Figure 1B) (Kim et al., 2010). Double mutants showed a
relatively normal organization of the marginal zone (Figure 1B), consistent with a genetic
interaction between the apical complex and Pten. The expression of apical complex
components, especially Cdc42, were abnormal in Pten cortex (Figure S1F and data not
shown). The proportion of proliferative progenitor cells marked by Ki67-positive staining
cells was greater in the double mutant cortex compared to conditional Pals1 heterozygotes
(Figure 1C) and brain size was also more normal by embryonic day (E) 14.5 (Figure S1G
and S1H). Proportions of early-born neurons marked by Tbr1 and Ctip2 were also more
normal in the PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/− mice than in either Pals1 or Pten
mutants alone (Figure 1D and data not shown). However, cells in the double mutant brain
appeared irregular in size and lamination (Figure 1D), a finding consistent with roles for
Pten in the regulation of cell size and polarity (Figure S1C) (Chalhoub et al., 2009; Groszer
et al., 2001), and with a role for Pten downstream of the apical complex.
The genetic interaction between Pals1 and Pten, and the decreased proliferation of
progenitors and prominent cell death in Pals1 mutants (Kim et al., 2010), prompted us to
test whether the apical complex interacts with Igf signaling, since Igfs play a prominent role
in cell cycle kinetics of cortical progenitors, cell survival, and brain size (Hodge et al., 2004;
Liu et al., 2009; Popken et al., 2004; Schubert et al., 2003). The Igf1R, which binds both
Igf1 and Igf2, mediates the proliferative response to Igf signaling (Weber et al., 1992).
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Surprisingly, Igf1R was enriched in cortical progenitors at the apical, ventricular surface,
interdigitating with β-catenin (Figure 2A-2D), suggesting the apical region as the likely site
for binding of Igf1R ligand. Apical Igf1R expression was strikingly decreased in
Pals1loxP/loxP/Emx1Cre+/− mice (Figure 2E). By contrast in the absence of Pten, Igf1R
immunoreactivity demonstrated a considerable basolateral spread in clusters of radial glia
(Figure 2F and data not shown). Analyses of downstream signaling events, using a specific
antibody against the phosphorylated form of Rsk substrate S6 ribosomal protein (phospho-
S6rp), revealed an apical pattern of activity within control brains (Figure 2G). In contrast in
Pten mutants, phospho-S6rp showed a broad distribution across the cortical tissue, with
many robust phospho-S6rp positive cells extending basally away from the lateral ventricle
(Figure 2G). While the majority of cells positive for Igf1R were clearly apical progenitors,
some upregulation of Igf1R in basal progenitors is possible. Though we cannot rule out that
Pals1 and Pten could function independently to regulate Igf signaling and cortical growth,
we interpret our data to suggest that within the cortical ventricular zone, Pals1 and Pten
spatially restrict IgfR expression and Igf signaling to the apical membrane domain.
Loss and gain of Igf signaling in mutant mice produced phenotypes similar to those seen
when apical complex signaling is disrupted. Mice with Igf1R deficiency limited to neural
precursors (Igf1RloxP/loxP/NestinCre+/−) were microcephalic (Figure 2H-J) (Kappeler et al.,
2008; Liu et al., 2009), and had a reduced frequency of phospho-Histone H3 (PH3, a marker
of cell division) proliferative progenitors in the ventricular zone (PH3-positive cells/100μm
VZ ± S.E.M. at E16.5: Control: 2.9 ± 0.3; Igf1RloxP/loxP/NestinCre+/−: 1.7 ± 0.1; unpaired t-
test, p<0.01; n=4 and n=3, respectively). We did not observe differences in progenitor cell
survival at the ventricular zone in these mice as assessed by cleaved caspase 3 (CC3)
immunoreactivity (data not shown). Conversely, mice with increased Igf activity (Igf1
expressed from the human GFAP promoter) were macrocephalic (data not shown) (Ye et al.,
2004), and had increased proliferative progenitors at the ventricular surface (PH3-positive
cells/100μm VZ ± S.E.M. at E18.5: Control: 0.9 ± 0.08; Igf1_Tg: 1.2 ± 0.07; unpaired t-test,
p<0.05, n=3 and n=4, respectively). Together with published work demonstrating that
Insulin receptor substrate 2 (Irs2) deletion leads to microcephaly (Schubert et al., 2003),
these data suggest that Igf signaling in cortical progenitors, facilitated at the apical surface
via Pals1 and an intact apical complex, regulates cortical development.
CSF-borne Igf signaling
The normal apical localization of the Igf1R, and the fact that we did not observe Igf1 or Igf2
mRNA in neural progenitor cells by in situ hybridization (Figure 3A, B, and data not shown)
(Ayer-le Lievre et al., 1991), suggested that progenitor cells may be exposed to Igfs derived
from the lateral ventricle CSF. We confirmed the presence of Igf2 in an unbiased tandem
mass spectrometry (LC-MS/MS) analysis of CSF (Table S1) (Binoux et al., 1986), and
detected Igf1 in CSF by ELISA (E14 CSF [Igf1]: 72.2ng/ml, n=2; E17 CSF [Igf1]: 69.6ng/
ml; adult CSF [Igf1]: 68.8ng/ml, n=3). Igf1 expression in the CSF remained stable across the
ages sampled (see above). In contrast, expression of Igf2 in rat CSF was temporally
dynamic; it peaked during periods of neurogenesis and declined in adulthood (Figure 3C).
High levels of Igf2 mRNA expression by the choroid plexus suggested this as a source of
CSF Igf2 (Figure 3B), and quantitative PCR revealed that rat choroid plexus expressed 10.7-
fold more Igf2 than its cortical counterpart at E17 (data not shown). We confirmed that Igf2
mRNA was also expressed in vascular endothelial cells, and leptomeninges in the rat
embryo at E14 and E17 as well as pericytes at E17 (Figure 3A, B and data not shown)
(Bondy et al., 1992; Dugas et al., 2008; Stylianopoulou et al., 1988), suggesting that extra-
choroidal sources of Igf2 may contribute to CSF-Igf2 content as well. Immunogold labeling
revealed Igf2 binding to progenitors along the apical, ventricular surface (Figure 3D).
Moreover, Igf2 binding to progenitors was highly enriched along primary cilia (Figure 3E),
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which extend directly into the ventricular space (Figure 3F) (Cohen et al., 1988). We did not
observe enriched Igf2 binding beyond the apical surface of ventricular zone progenitor cells
(data not shown). Thus, the robust expression of Igf2 by the choroid plexus and the apical
binding of Igf2 to progenitors along the ventricular zone strongly suggest that the CSF
distributes choroid plexus secreted Igf2 to cortical progenitor cells.
Purified rat E17 CSF directly stimulated Igf1R mediated signaling activity, reflected by
Igf1Rβ phosphorylation as well as phosphorylation of Akt and MAPK (Figure 3G), two
downstream targets of Igf signaling as well as other growth factors that may be present in
CSF. Igf2 treatment by itself induced Igf signaling similar to embryonic CSF (Figure 3G).
Igf2 binding to progenitors, the localization of the Igf1R, its phosphorylation, as well as the
phosphorylation of its downstream targets Akt and MAPK in response to CSF, strongly
suggest that the CSF is a primary source of Igf ligands for cerebral cortical neuroepithelial
cells, although additional sources cannot be completely excluded.
We next tested whether Igf2 supports progenitor proliferation in a cerebral cortical explant
system. In this system, rat embryonic cortex dissected from the lateral pallium is placed on
polycarbonate membranes and floated on defined media (Figure 3H). We found that Igf2
added to Neurobasal Medium (NBM) with 20% artificial CSF (ACSF) stimulated the
proliferation of progenitor cells marked by phospho-Vimentin 4A4 in rat cortical explants
(Figure 3I) (Noctor et al., 2002). In addition, Igf2 treatment alone maintained GLAST-
positive neurospheres, an in vitro model of neural stem cells, even in the absence of Fgf2
(Fibroblast growth factor 2) and Egf (Epidermal growth factor) (Figure 3J) (Vescovi et al.,
1993). Finally, pharmacologic activation of the signaling pathway with insulin demonstrated
that activation of Igf signaling by ligands other than Igf2 is sufficient to stimulate
proliferation (PH3-positive cells/100μm VZ ± S.E.M. in E16 rat explant: control mean: 5.6
± 0.7; insulin (10ug/ml) mean: 11.2 ± 0.4; Mann-Whitney, p<0.05; n=6). Therefore, Igf
signaling modulates proliferation of isolated cortical precursors or those maintained in their
pallial environment in vitro.
CSF promotes proliferation of progenitor cells in an age-dependent manner
Since the CSF is a complex fluid containing many factors including Igf binding proteins that
may modulate Igf2 bioavailability and signaling (Table S1) (Clemmons, 1997; Zappaterra et
al., 2007), we tested whether native CSF alone could support cortical tissue growth. We
used a heterochronic “mix-and-match” approach for exposing cortical tissue to CSF
collected at different ages. E16 rat cortical explants with intact meninges and vasculature
cultured with 100% E17 rat CSF for 24 hours, without any additional exogenous media or
factors, retained remarkable tissue architecture, cell viability and proliferation,
approximating in vivo E17 rat cortex (Figure 4C). In contrast, E16 explants cultured with
100% artificial CSF failed to thrive, had decreased mitotic activity, disorganized neuronal
morphology, and increased cell death (Figure 4C, Figure S2A and S2B). Filtration analysis
of E17 CSF showed that the sizes of CSF factors that support stem cells likely range from
10kDa – 100kDa, suggesting that they are proteins (Table S2 and data not shown). Thus, the
embryonic CSF proteome provides essential growth and survival factors for the developing
cortex.
By comparing rat CSF from several ages, we determined that the effects of CSF on survival
and proliferation are strikingly age-dependent, and mimicked the temporal profile of CSF-
Igf2 expression (Figure 3C). E17 CSF (near the middle of neurogenesis) maintained the
healthiest explants and produced the maximal increase in the frequency of PH3 labeled
proliferating cells in E16 cortical explants compared to explants cultured with E13 (early in
neurogenesis), P6, or adult CSF (Figure 4D, E, Figure S2C, and data not shown). Many
mitotic cells were identified as proliferating neuroepithelial progenitor cells by their
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immunoreactivity for phospho-Vimentin (4A4, Figure 4F and Figure S2C). In contrast, no
differences were seen in Tbr2-positive basal progenitors, which do not contact the CSF
directly (data not shown). Together, these data suggest that age-dependent differences in
CSF signals are both supportive and instructive for neuroepithelial precursor proliferation in
the developing cortex. The CSF effects may be specific to neuroepithelial progenitors,
which contact the ventricle through the apical complex, without affecting the intermediate
progenitors of the SVZ.
We tested directly whether CSF-borne Igf2 was necessary to explain the effects of age-
specific CSF on rat cortical explants. The frequency of proliferating cells declined in
explants grown in E17 CSF in the presence of Igf2 neutralizing antibodies (Igf2 Nab; Figure
4G). Igf2 neutralization with Igf2 NAb did not interfere with Igf1 levels in CSF compared to
control as assayed by ELISA (data not shown). While Igf signaling is known to promote
neuronal survival (Popken et al., 2004), we did not observe differences in ventricular
progenitor cell survival in these explant experiments (data not shown), suggesting that Igf
actions on neural cell survival likely depends on the cell type, developmental stage, and
microenvironment. These data confirm the important role for CSF borne Igf2 in regulating
cerebral cortical progenitor cells, but do not rule out roles of other CSF borne factors as
well.
CSF influence on isolated neural stem cells requires Igf signaling
Neural stem cells cultured as neurospheres confirmed the age-dependent capacity of CSF to
maintain neural stem cells (Reynolds and Weiss, 1996), and provided additional evidence
suggesting that Igf2 mediated signaling is an essential determinant of CSF activity on neural
stem cells. CSF from any age supported the proliferation and maintenance of isolated
cortical stem cells cultured as primary or secondary neurospheres (Figure 4H and data not
shown) (Vescovi et al., 1993). However, E17 CSF was maximally effective in generating
increased numbers of neurospheres, larger neurospheres, and maintained neurospheres even
in long-term cultures for up to 44 days in vitro (Figures 4H, S2D-S2G, and data not shown).
Neurospheres grown in CSF retained responsiveness to Fgf2 and Egf, indicating that the
CSF maintains stem cells in an uncommitted fate (Figure S2H). CSF generated neurospheres
from adult SVZ precursors as well (Figure 4I). Consistent with these observations and our
explant studies, the Igf1R inhibitor picropodophyllin blocked the formation of spheres in the
presence of E17 CSF (data not shown). Our data suggest that the choroid plexus is the most
prominent source of Igf2 in CSF (Figures 3 and S3A). Accordingly, media conditioned with
E17 choroid plexus provided enhanced support for neurosphere formation compared to
media conditioned with embryonic cortex, adult choroid plexus, or adult brain (Table S3),
demonstrating that one or more factors actively secreted from the embryonic choroid plexus,
including potentially Igf2, is sufficient for stem cell growth and maintenance. Thus, distinct
factors secreted by the choroid plexus into the embryonic CSF, including Igf2, confer E17
CSF with an age-associated advantage to stimulate and maintain neural stem cell
proliferation, and Igf signaling is likely one pathway that promotes this process.
Genetic inactivation of Igf signaling impairs brain development
Mouse explant experiments confirmed a requirement for Igf signaling in the proliferation of
progenitor cells. Mouse embryonic CSF supported the survival and proliferation of mouse
cortical progenitors (C57BL/6 explants: ACSF mean: 7.4 ± 0.2; E16.5 mean: 14.1 ± 1.4;
Mann-Whitney; p<0.01; n=3), and purified Igf2 in ACSF stimulated cortical progenitor
proliferation (Figure 5A). When the Igf1R was genetically inactivated in cortical progenitors
(Igf1RloxP/loxP/NestinCre+/−) (Liu et al., 2009), wild type CSF no longer stimulated cortical
progenitor proliferation (ACSF: 17.6 ± 2.9; E16.5 CSF: 16.4 ± 3.0; Mann-Whitney; N.S.;
n=3). Importantly, CSF obtained from Igf2−/− mice failed to stimulate progenitor
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proliferation in wild type explants compared to control (Figure 5B), suggesting that Igf2 in
its native CSF environment stimulates proliferation of progenitor cells during cerebral
cortical development.
As expected for the roles we have shown for Igf2 in regulating proliferation, we found that
Igf2-deficiency reduced brain size. Igf2−/− brain weight decreased by 24% at P8 compared
to controls (Figures 5C, D). Accordingly, the overall cortical perimeter and surface area
were reduced in Igf2−/− brains compared to controls as well (Figures 5E-G). Profound
defects in somatic size couple to brain size (Purves, 1988). As previously reported
(DeChiara et al., 1991; Baker et al., 1993), Igf2−/− body weight was reduced compared to
control (mean body weight (g) at P8: Igf2+/+: 5.6 ± 0.01; Igf2−/−: 2.8 ± 0.1; Mann-Whitney;
p<0.0001; n=11), suggesting that Igf2 may be a secreted factor that scales brain size to body
size. Consistent with the mouse CSF Igf2 expression pattern that is significantly increased
during later embryonic development (Figure S3B), blunting Igf2 expression markedly
reduced the proliferating progenitor cells at E16.5 compared to controls (PH3-positive cells/
100μm VZ ± S.E.M. at E16.5: Igf2+/+: 2.5 ± 0.3; Igf2−/−: 1.7 ± 0.1; Mann-Whitney; p<0.05;
n=5) (DeChiara et al., 1990). NeuN- and late-born Cux1-staining neurons were reduced in
Igf2−/− mice (Figure 5H and data not shown), confirming that Igf2 contributes to cortical
progenitor proliferation and to late stages of neurogenesis. Taken together, our genetic
experiments support a model in which the apical complex localizes Igf signaling in
progenitors by ensuring the apical, ventricular localization of the Igf1R. In this manner, the
apical complex couples cell autonomous and extracellular signals to the regulation of
cortical development.
Glioblastoma CSF expresses high Igf2
Our data, together with recent findings implicating Igf signaling in the maintenance of adult
neural stem cells (Llorens-Martin et al., 2010), raised the possibility that abnormalities of
the CSF may be relevant to conditions showing abnormal proliferation, including in
glioblastoma multiforme (GBM), a malignant astrocytic brain tumor. Igf-PI3K-Akt
signaling has been implicated as a key regulator of gliomagenesis (Louis, 2006; Soroceanu
et al., 2007), and mutations in PTEN are commonly found in patients with GBM (Louis,
2006). We analyzed Igf2 concentration in a panel of 56 human GBM patient CSF samples
collected from 21 individuals representing the full-range of disease progression, and 8
disease-free controls, and found that CSF from GBM patients contained significantly more
Igf2 than CSF from disease-free controls (Igf2 concentration expressed as mean ± S.E.M.
for GBM patients: 340.4 ± 12.9ng/ml; n=56; disease-free controls: 222.9 ± 41.5ng/ml; n=8;
Mann-Whitney, p<0.01). Three GBM samples containing the highest Igf2 concentrations
(605.8ng/ml, 502.8ng/ml, and 468.7ng/ml) came from patients with advanced disease
(Figure 6A and Table 1). By contrast, the three patients with the lowest levels of Igf2
(142.1ng/ml, 145.4ng/ml, and 148.2ng/ml) all had early or stable glioma (Figure 6A and
Table 1). Similar to rodent ventricular CSF, human lumbar CSF stimulated cortical
progenitor cell proliferation in our explant assay, with CSF from GBM patients causing
greater proliferation than CSF from disease-free controls (Figure 6B). Moreover, human
GBM patient CSF neutralized with Igf2 antibodies failed to stimulate the proliferation of
progenitor cells (Figure 6B; Igf2 concentration following NAb absorption: GBM1(PBS):
605.8ng/ml; GBM1(NAb): 45.6ng/ml; GBM2(PBS): 502.8ng/ml; GBM2(NAb): 218.3ng/
ml; GBM3(PBS): 468.7ng/ml; GBM3(NAb): 248.8ng/ml). Taken together, these data
suggest that beyond embryonic brain development, CSF-Igf2, in particular, is a potential
mediator of GBM pathology, and that the CSF mechanisms that normally regulate neural
stem cells are misregulated in GBM.
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CSF-mediated long-range distribution of additional secreted factors
Whereas our studies suggest an important role for Igf2 in controlling proliferation in late
stages of neurogenesis and potentially postnatally, they do not rule out the presence of other
secreted factors that may act at long ranges via the CSF, and so we performed functional
screening tests for several other families of factors. The CSF contained Wnt signaling
activity (Zhou et al., 2006), based upon phosphorylation of LRP6, a Wnt co-receptor in
response to CSF exposure (Figure 7A). Several Wnt ligands were expressed along the
ventricular surface and in the choroid plexus (Figure 7B and data not shown) (Grove et al.,
1998). Frizzled (Fz) receptors, which bind LRP6 to transduce Wnt signals, showed enhanced
expression in ventricular progenitors (Figure 7B and data not shown) (Zhou et al., 2006),
suggesting that CSF may distribute Wnts to precursors throughout the ventricular surface.
Additional signaling activities that influence cortical development were also found in the
CSF, with responsive cells seen broadly in the ventricular zone. There were dynamic levels
of Bone morphogenetic protein (Bmp) activity in the CSF during different stages of cortical
development (Figure 7C). Using a luciferase-based assay in which overall Bmp activity can
be quantified between 0.1-100ng/ml (data not shown), we found that Bmp activity in the
CSF decreased during embryogenesis and peaked in adulthood (Figure 7C). CSF-borne Bmp
activity may be responsible for stimulating progenitors widely throughout the cortical
ventricular zone in vivo, based on widespread labeling for nuclear phospho-SMAD1/5/8
(Figure 7D) in the absence of any known Bmp ligands localizing to the ventricular zone
(Shimogori et al., 2004), whereas Bmps 2, 4, 5, and 7 are expressed in embryonic and adult
choroid plexus (Figure 7E) (Hebert et al., 2002; Shimogori et al., 2004). Moreover, Growth
and Differentiation Factors 3 and 8 (GDF3 and GDF8), both members of the TGF-β
superfamily of proteins that can influence Bmp signaling (Levine and Brivanlou, 2006) were
found in our MS analyses of CSF (data not shown), though we do not consider our MS
analysis to have recovered all potential smaller ligands in the CSF. Retinoic acid (RA)
(Haskell and LaMantia, 2005; Siegenthaler et al., 2009) activity in CSF also varied over the
course of cortical development (Figure 7F). A luciferase-based assay that quantifies RA
activity ranging between 10−9-10−6M (data not shown) revealed that RA activity in CSF
peaked early and decreased in adulthood (Figure 7F). In parallel, RA responsive cortical
progenitors localized to the developing ventricular zone (Figure 7G). Similar to Wnts and
Bmps, RA is most likely released into CSF since RA synthetic and catabolic enzymes were
expressed in the choroid plexus (Figure 7H) and meninges (data not shown). Thus, CSF
shows bioavailability of a wide range of activities known to regulate neurogenesis,
patterning, and neuronal survival in the cerebral cortex and throughout the CNS.
Discussion
We show that the CSF plays an essential, active role in distributing signals in the central
nervous system. The key findings of our study are: (1) the apical complex is essential for the
apical localization of Igf1R; (2) Pten deficiency in the Pals1 background results in an almost
normally sized brain; (3) CSF Igf2 binds to the apical domain of cortical progenitor cells,
stimulating their proliferation in an age-dependent manner; (4) Igf2 is upregulated in GBM
patient CSF, contributing to the range of proliferative activities of GBM patient CSF; and
(5) the CSF provides an adaptive library of secreted factors throughout life. The dynamic
regulation of several potent modulators of neural stem cells reinforces the central
relationship between local signaling at the apical surface via ligands delivered by the CSF
during cortical neurogenesis.
Asymmetric growth factor-based signaling
It has been suggested that asymmetry of signaling at the apical versus basolateral aspect of
cortical progenitors regulates progenitor progress through the cell cycle (Bultje et al., 2009;
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Sun et al., 2005). The basolateral expansion of the Igf1R signaling domain we report in Pten
mutants suggests potential links between asymmetric growth factor signaling and
proliferation. Although asymmetric localization of the EgfR in cortical progenitors has
previously been reported (Sun et al., 2005), the ventricular enrichment of the Igf1R was not
known and raises the possibility that the apical enrichment of the Igf1R along with other
apical proteins confers a differential responsiveness to mitogenic signals, akin to Notch
signaling (Bultje et al., 2009). Since Igfs are potent mitogens for cortical progenitors (Hodge
et al., 2004; Popken et al., 2004), one model might suggest that inheritance of the apical
complex promotes progenitor fate by differentially concentrating Igf1R and its downstream
signaling proteins into cells that retain their perikarya or at least a process (likely a cilium)
in the ventricular zone, causing these cells to remain in the cycling pool. The presence of
proliferation-inducing factors in the CSF suggests that withdrawal of the progenitor’s apical
ventricular process may be an important step in neuronal differentiation (Cappello et al.,
2006), by insulating progenitor cells from proliferative signals in CSF, with vascular niches
potentially supplying sources of secreted factors for stem cells at other stages (Palmer et al.,
2000; Shen et al., 2004; Shen et al., 2008; Tavazoie et al., 2008).
Our data provides a new perspective on the production and provision of Igf ligands, which
are known to regulate stem cell populations in the brain and other proliferative epithelia
(Bendall et al., 2007; Hodge et al., 2004; Liu et al., 2009; Popken et al., 2004; Ye et al.,
2004; Zhang and Lodish, 2004). In the E17 rat brain, the choroid plexus was the strongest
source of Igf2, though we cannot discount a contribution by the vasculature or other cellular
sources of Igf2 that may percolate into the CSF. Indeed, both pericytes and endothelial cells
express Igf2 (Dugas et al., 2008), and Igfs from vascular tissue may have local effects
beyond apically-mediated Igf1R signaling shown here. Thus, locally-derived Igf2 may play
distinct roles at different developmental time points and in different cellular contexts, and
Igf signaling may also be influenced by CSF Igf1 and insulin. Although Igf2 availability
decreased in adult CSF (Figures 3C and S3B), Igf2 continued to be expressed in adult
choroid plexus (data not shown) and maintained adult neurospheres (Figure 4I), suggesting
that low levels of CSF Igf2 contribute to the maintenance of adult neural stem cells. The
aberrant increase in Igf2 in advanced GBM patients reinforces the hypothesis that Igf
signaling has an influence on proliferation of cortical precursors. Our identification of Igf2
regulation of neurogenesis and brain size complements a literature in which Igf signaling is
well known to influence body and brain size (Baker et al., Cell 1993; DeChiara et al., 1991;
Purves, 1988), raising the intriguing possibility that Igf2 represents a secreted factor that
may scale brain size to body size.
Fluid-based signaling in the CNS and beyond
The activity of growth promoting factors in the CSF and their action on progenitors across
the apical surface may be a model for other epithelia including lung, gut, and vascular
endothelia that develop in relation to extracellular fluids (Bendall et al., 2007; Scadden,
2006). Extracellular fluid apparently regulates the microenvironment of hematopoietic stem
cells, where Igf signaling regulates progenitor proliferation (Orkin and Zon, 2008; Zhang
and Lodish, 2004). The differential capacity of Igf signaling to confer a proliferative
advantage to stem cells may be regulated in part by Igf’s interactions with binding proteins
or other secreted factors in the environment (Clemmons, 1997). Our experiments focused on
the age-associated effects of CSF on survival and proliferation across the cortical ventricular
zone. However, the distribution of CSF resident proteins, as well as the flow of the CSF,
may also influence ciliary orientation and maturing ependymal cell polarity (Mirzadeh et al.,
2010), which create activity gradients as has been shown for Slit (Sawamoto et al., 2006).
If a major component of the stem cell niche reflects secreted factors acting at long distances
from their sources, modulation of the proteomic composition of extracellular fluids may also
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provide unexpected ways to regulate stem cell behavior in health and disease. For example,
while Igf2 activity peaked in embryonic CSF, some CSF-borne Igf persisted in adulthood
(Figure 3, Figure S3B, and data not shown). Igf2 and Igf1 in adult CSF may contribute to
the retention of neural stem cell properties in the adult SVZ (Doetsch et al., 1999).
Importantly, the regulation of CSF growth factors may also extend to pathologic states. Igf2
and other diffusible growth factors that drive neural progenitor proliferation during
development are upregulated in some GBM patients (Louis, 2006; Soroceanu et al., 2007),
and GBM patients have elevated Igf2 levels in their CSF. CSF Aβ1-42 and phosphorylated
Tau levels were recently shown to assist in Alzheimer’s disease diagnosis (De Meyer et al.,
2010). Thus, modulation of the proteomic composition of extracellular fluids together with
the integration of cell autonomous determinants of self-renewal by the apical complex may
ultimately provide unexpected ways to regulate stem cell behavior in health and disease.
EXPERIMENTAL PROCEDURES
Animals
Time pregnant Sprague Dawley, C57BL/6, and Swiss Webster dams were purchased from
Charles River Laboratories and Taconic. Pals1loxP/loxP/NestinCre+/−, Pals1loxP/loxP/
Emx1Cre+/−, Igf1RloxP/loxP/NestinCre+/− and GFAP:Igf_1Tg mice were obtained from
heterozygous breedings, and PtenloxP/+/Pals1loxP/+/Emx1Cre+/− and PtenloxP/loxP/
Pals1loxP/+/Emx1Cre+/− mice were obtained from PtenloxP/+/Pals1loxP/loxP/Emx1Cre+/− and
PtenloxP/loxP/Emx1Cre−/− crosses (Groszer et al., 2001; Kim et al., 2010; Liu et al., 2009; Ye
et al., 2004). Igf2−/− and control CSF was collected from embryos obtained from
homozygous breedings. Igf2−/− and control P8 brains were obtained from homozygous
crosses or paternal heterozygotes mated with homozygous knockouts (DeChiara et al.,
1991). All animal experimentation was carried out under protocols approved by the IACUCs
of Harvard Medical School, Children’s Hospital Boston, and UNC-Chapel Hill.
Antibodies
The following antibodies were purchased: Ctip2, Igf2 (for EM), Tbr2 (Abcam); BrdU (AbD
Serotec); Ki67 (Abnova); Vimentin 4A4 (Assay Designs); Pax6 (Developmental Studies
Hybridoma Bank); β-catenin, Cdc42 (BD Biosciences); AKT, phospho-AKT, Igf1R,
phospho-Igf1R, CC3, and phospho-S6rp (Cell Signaling); GLAST (Chemicon); Tuj1
(Covance); HRP conjugated anti-Transferrin (Immunology Consultants Laboratory, Inc.);
Igf2 (NAb; Millipore); Cux1, Igf2 (for WB) (Santa Cruz Biotechnology); and phospho-
Histone H3 (Upstate). Tbr1 was a kind gift of R. Hevner.
CSF isolation
Embryonic rodent CSF, isolated as described (Zappaterra et al., 2007), was kept on ice
during collection, centrifuged at 10,000g at 4°C for 10 min., and stored at −80°C. Human
GBM and disease-free CSF samples were collected by lumbar puncture from patients
undergoing clinical evaluation. The 56 GBM samples tested were obtained from 21
individuals representing the full-range of disease progression. The samples used in analyses
of highest and lowest CSF Igf2 concentration were obtained from distinct individuals. All
research was approved by the IRBs at BIDMC and Children’s Hospital Boston.
Cortical explants
The telencephalic wall was dissected onto polycarbonate membranes (Whatman; 13mm,
8.0um) and cultured for 24 hours as described in text. Artificial (A)CSF (NaCl 119mM, KCl
2.5mM, NaHCO3 26mM, NaH2PO4 1mM, Glucose 11mM, MgCl2 2mM, CaCl2 2.8mM)
was supplemented with Igf2 (2ng/ml; US Biologicals) as indicated. Igf2 NAb antibody was
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incubated with E17 CSF for 1 hour at 4°C. Explants were pulsed with BrdU for 30 minutes
and fixed (60% methanol, 30% chloroform, and 10% acetic acid; 10 minutes). For in vivo
BrdU labeling, pregnant dams were administered a 3 hour BrdU (60mg/kg) pulse. Tissue
was paraffin sectioned (5μm).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The apical complex and Pten modulate brain size
(A) Conditional Pten deletion (PtenloxP/loxP/Emx1Cre+/−) resulted in hyperplagia and an
enlarged cerebral cortex. Ablation of Pten in PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/− mice
largely restored the small brain phenotype of Pals1loxP/+/Emx1Cre+/− neonates. (B) H&E
staining of PtenloxP/+/Pals1loxP/+/Emx1Cre−/−, PtenloxP/+/Pals1loxP/+/Emx1Cre+/−, and
PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/− neonates. Arrowheads point to marginal zone. (C)
The proportion of Ki67-positive staining progenitors was restored in the E14.5 PtenloxP/loxP/
Pals1loxP/+/Emx1Cre+/− cortex compared to PtenloxP/+/Pals1loxP/+/Emx1Cre+/− (Percent
Ki67-positive staining cells ± S.E.M.; PtenloxP/+/Pals1loxP/+/Emx1Cre−/−: 65.6 ± 2.3;
PtenloxP/+/Pals1loxP/+/Emx1Cre+/−: 58.4 ± 2.0; PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/−: 75.8
± 0.4; ANOVA, p<0.01, n=3). (D) Left panels: Representative images of Ctip2-positive and
Tbr1-positive staining neurons analyzed in PtenloxP/+/Pals1loxP/+/Emx1Cre−/−, PtenloxP/+/
Pals1loxP/+/Emx1Cre+/−, and PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/− neonates. Right panels:
The cortical plate was subdivided into six equal bins and Ctip2 and Tbr1 positive cells
quantified per bin are expressed as percent of total cells per bin. Pten deletion in the
PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/− mice restored the proportions of early-born cells
marked by Tbr1 and Ctip2 (Percent positive staining cells/total: PtenloxP/+/Pals1loxP/+/
Emx1Cre−/− Ctip2 = 8.13 ± 2.0, Tbr1 = 38.7 ± 2.4; PtenloxP/+/Pals1loxP/+/Emx1Cre+/−
Ctip2 = 1.6 ± 1.2, Tbr1 = 18.8 ± 3.1; PtenloxP/loxP/Pals1loxP/+/Emx1Cre+/− Ctip2 = 8.5 ±
1.6, Tbr1 = 39.1 ± 2.6; ANOVA, p<0.05, n = 3). See also Figure S1.
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Figure 2. Igf1R expression in cortical progenitor cells
(A) Left panel: Igf1R in situ hybridization at E14.5 mouse. Right panel: High magnification
image of area denoted in left panel. (B) Igf1R enriched along the ventricular surface of E17
rat cortex. (C) Confocal images of Igf1Rβ and β-catenin immunostaining in rat E17
ventricular zone. (D) En face view of the mouse E16.5 ventricular zone immunostained with
Igf1Rβ and β-catenin. (E) Ventricular Igf1R expression was disrupted in E12.5
Pals1loxP/loxP/Emx1Cre+/− cortex. (F) Left panel: Igf1R expression was enriched along the
apical, ventricular zone of E14.5 PtenloxP/+/NestinCre+/− controls. Right panel: Igf1R
expression expanded basolaterally in PtenloxP/loxP/NestinCre+/− radial glia. (G) Left panel:
pS6rp activity along the ventricular progenitors of E14.5 PtenloxP/+/NestinCre+/− controls.
Right panel: pS6rp localization extended basolaterally in PtenloxP/loxP/NestinCre+/− radial
glia. See also Figure S1. (H) Igf1R deficiency in NestinCre expressing cells diminished
brain size at E16.5. (I) Brain weights of Igf1RloxP/loxP/NestinCre+/− and controls at E16.5
(brain weight (g) ± S.E.M.: Igf1RloxP/loxP/NestinCre+/−: 0.06; Igf1RloxP/loxP/NestinCre+/−:
0.03 ± 0.001; n = 2 [+/+], n = 3 [−/−]). (J) H&E staining of brains shown in panel (I).
Lehtinen et al. Page 16













Figure 3. Igf2 is expressed in cerebrospinal fluid and stimulates progenitor proliferation
(A, B) Igf2 in situ hybridization of rat E14 and E17 cortex. Arrow points to choroid plexus.
(C) Transient Igf2 expression in rat CSF. (D) Immunogold labeling of endogenous Igf2 in
E17 rat brain. Left panel: no primary control. Right panel: Igf2 binding to ventricular
surface of cortical progenitors. Scale bar represents 500nm. (E) Igf2 binding to primary
cilium of cortical progenitor cell. Arrow points to ciliary basal body. Scale bar represents
500nm. (F) Scanning EM of mouse ventricular surface at E12.5. Arrowheads point to
primary cilia projecting into the ventricular space. Scale bar represents 2μm. (G) Lysates of
cortical cells deprived of growth factors for 6 hours and treated with ACSF, E17 CSF, or
Igf2 for 5 minutes were immunoblotted with antibodies to P-Igf1R, P-Akt, Akt, P-ERK1/2,
and ERK1/2. (H) Schematic of cortical explant dissections: explant placed on membrane
with ventricular side down contacting CSF and notch making medial-caudal side. (I) Left
panels: E16 explants cultured with NBM plus ACSF (control) or with supplemental Igf2
immunostained with anti-Vimentin 4A4 and Hoechst represented as mean ± SEM (Igf2
mean: 36.7 ± 2.1; control mean: 20.4 ± 4.46; n = 8; Mann-Whitney; p<0.005). Vimentin
4A4-positive cells increased in explants cultured with Igf2 compared to control. Right
panels: Representative images of explants quantified in left panels. (J) Single cells
dissociated from primary neurospheres cultured in control media or control media
containing Igf2 (20ng/ml). Igf2 stimulated secondary sphere formation after 10 DIV (Igf2
mean: 39.3 ± 4.1; control mean: 2.2 ± 0.75; n = 3; t-test; p<0.005).
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Figure 4. Embryonic CSF supports cortical explant viability and stimulates proliferation of
neural progenitor cells
(A) Total CSF protein concentration over rat development. (B) Silver stain of embryonic rat
CSF revealed a dynamic fluid with numerous changes in protein composition over time.
Asterisks indicate proteins with varying CSF expression during development. (C) E17 rat
cortex and E16 explants grown for 24 hours in 100% embryonic E17 CSF or 100% artificial
CSF respectively. Upper panels: anti-PH3 (red), and anti-Tuj1 (green), Hoechst (blue)
immunostaining. Lower panels: anti-BrdU (red), and anti-Tuj1 (green) immunostaining.
Explants cultured in 100% E17 CSF in vitro maintained tissue histology similar to embryo
in vivo. Survival and proliferation of explants cultured with E17 CSF indicated by
immunoreactivity for PH3 along the ventricular surface, BrdU incorporation in the
ventricular zone, and Tuj1-positive-staining neurons in the developing cortical plate. (D)
E16 explants cultured in 100% E13, E17, P6, or adult CSF for 24 hours were
immunostained with anti-PH3 (red) and Hoechst (blue)(see Figure S2C). Quantification of
total PH3-positive-staining cells per 400μm explant showed that proliferating cells increased
in explants cultured with E17 CSF compared to E13, P6, or adult CSF. Immuno-positive
cells are represented as mean ± SEM (E17 mean: 44.1 ± 1.43; E13 mean: 25 ± 4.2; P6 mean:
9.2 ± 0.8; adult mean: 9.6 ± 0.9, n = 4; Kruskal-Wallis; p<0.005). (E) Quantification of
ventricular PH3-staining cells in explants (panel D). PH3-positive cells along the ventricle
were significantly increased in explants cultured with E17 CSF compared to E13, P6, or
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adult CSF (E17 mean: 32.3 ± 0.79; E13 mean: 12.8 ± 3.9; P6 mean: 4.9 ± 1.0; adult mean:
6.9 ± 0.73; n = 4; Kruskal-Wallis; p<0.01). (F) E16 explants (panel D) immunostained with
anti-Vimentin 4A4 (green)(see Figure S2C) were quantified. Vimentin 4A4-positive cells
were significantly increased in explants cultured with E17 CSF compared to E13, P6, or
adult CSF (E17 mean: 37.1 ± 1.4; E13 mean: 14.9 ± 1.9; P6 mean: 6.1 ± 1.05; adult mean:
7.3 ± 0.6; n = 4; Kruskal-Wallis; p<0.005). (G) Left panels: E16 explants cultured in control
E17 CSF or E17 CSF with Igf2 neutralizing antibody (Igf2 NAb), immunostained with anti-
Vimentin 4A4 and Hoechst (E17 control mean: 28.8 ± 4.3; E17 IGF2 NAb mean: 13.9 ±
2.0; n = 4; Mann-Whitney; p<0.05). Vimentin 4A4-positive cells decreased in explants
cultured with E17 CSF plus Igf2 NAb compared to control. Right panels: Representative
images of explants quantified in left panels. (H) Primary neurospheres derived from E14.5
cortex were grown in 20% E13/E14, E17, P6, or adult CSF for 10 days in vitro (DIV). E17
CSF generated the most spheres/cm2 (E17 mean: 274 ± 8.0; E13 mean: 77 ± 7.0; P6 mean:
110 ± 17.5; adult mean: 81 ± 8.8; n = 3; ANOVA; p<0.005). See also Figure S2. (I)
Neurospheres derived from adult rat SVZ were cultured in artificial (A)CSF, Igf2 (20ng/ml),
E17 CSF, or adult rat CSF for 10DIV. Igf2, E17 CSF, and adult CSF supported the growth
and maintenance of adult neurospheres (ACSF: 4.76 ± 0.67; Igf2: 17.3 ± 3.2; E17 CSF:
101.7 ± 15.8; Adult CSF: 67.8 ± 12.6; Kruskal-Wallis: Igf2 vs. E17 CSF, p<0.05; E17 CSF
vs. Adult CSF, N.S.; n=3). See also Figure S2.
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Figure 5. CSF Igf2 regulates progenitor proliferation and brain size
(A) Left panels: E15.5 C57BL/6 explants cultured in NBM supplemented with 20% ACSF
or ACSF/Igf2. Igf2 stimulated the proliferation of PH3-positive cortical progenitor cells
(C57BL/6 explants: ACSF mean: 7.4 ± 0.2; E16.5 mean: 14.1 ± 1.4; Igf2 mean: 11.2 ± 0.3;
Kruskal-Wallis; E16.5 vs. ACSF, p<0.01; Igf2 vs. ACSF, p<0.05; E16.5 vs. Igf2, N.S.;
n=3). Right panels: Representative images of explants quantified in left panels. (B) E15.5
C57BL/6 explants cultured in NBM supplemented with 20% ACSF or E16.5 Igf2−/− CSF.
Igf2-deficient CSF failed to stimulate progenitor cell proliferation compared to control
(ACSF: 17.9 ± 0.8; Igf2−/− CSF: 11.4 ± 1.0; Mann-Whitney; p<0.06; n=3 and n=4,
respectively). (C) Representative images of P8 Igf2−/− and control brains. (D) Igf2-
deficiency reduced P8 brain weight (Igf2+/+: 0.34g ± 0.008; Igf2−/−: 0.26g ± 0.004; Mann-
Whitney, p<0.0001, n=11). (E) Igf2-deficiency reduced P8 cortical perimeter (Igf2+/+:
30.9mm ± 0.01; Igf2−/−: 26.4mm ± 0.1; Mann-Whitney, p<0.0001, n=11). (F) Igf2-
deficiency reduced P8 cortical surface area (Igf2+/+: 13.0mm2 ± 0.1; Igf2−/−: 9.4mm2 ± 0.1;
Mann-Whitney, p<0.0001, n=11). (G) H&E staining of Igf2−/− and control brains at P8. (H)
Left panels: Igf2−/− brains have reduced numbers of upper layer neurons marked by Cux1
(Total Cux1-positive staining cells in equally sized cortical columns expressed as mean ±
S.E.M.: Igf2+/+: 157 ± 1.5; Igf2−/−: 131.3 ± 3.3; t-test, p<0.005, n=3). Right panels:
Representative images of Igf2−/− and control brains quantified in left panels. See also Figure
S3.
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Figure 6. Glioblastoma CSF Igf2 supports progenitor proliferation
(A) MRI scans from subjects with low and high CSF Igf2 levels. Gadolinium-enhanced T1-
weighted (T1-Gad) MRI sequence delineated the contrast-enhanced portion of the tumor
where tumor angiogenesis developed. Fluid attenuation inversion recovery (FLAIR) images
included area of non-vascularized and invasive tumor (Macdonald et al., 1990). (B) 20%
human GBM CSF in NBM stimulated PH3-positive proliferating cells compared to an
average of 3 disease-free control CSFs in E16 rat explants (control = 16.0 ± 4.1 (n=3);
GBM1 = 32.3 ± 4.3 (n=4); GBM2 = 23.0 ± 2.8 (n=5); GBM3 = 23.4 ± 3.8 (n=4); Mann-
Whitney, p<0.05). Igf2(NAb) inhibited GBM CSF-stimulated progenitor proliferation
(GBM1 = 13.5 ± 2.9 (n=4); GBM2 = 9.0 ± 2.7 (n=4); GBM3 = 13.0 ± 1.5 (n=3); Mann-
Whitney, p<0.05). CSF Igf2 concentration before and after Igf2 NAb absorption:
GBM1(PBS) = 605.8ng/ml; GBM1(NAb) = 45.6ng/ml; GBM2(PBS) = 502.8ng/ml;
GBM2(NAb) = 218.3ng/ml; GBM3(PBS) = 468.7ng/ml; GBM3(NAb) = 248.8ng/ml).
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Figure 7. The CSF proteome coordinates multiple signaling pathways that regulate brain
development
(A) Lysates of cortical cells were left untreated or treated with 20% ACSF or E17 CSF and
10% Wnt3a conditioned medium or its control medium for 2 hours and subjected to
immunoblotting with the P-LRP6 or LRP antibodies. (B) In situ hybridization for Wnt5a and
Fz1 in mouse E14.5 cortex. (C) Bmp activity was measured in E14, E17, and adult rat CSF
as luciferase signal in a clonally derived Bmp-sensitive cell line. Responses were compared
to linear responses generated in the same cell line by pure ligand (Bmp4; data not shown).
Bmp activity levels varied with age, and were statistically significant between E17 and adult
(ANOVA, p<0.001; n=4). (D) Top panel: Expression and nuclear localization of phospho-
Smad (P-SMAD) 1/5/8 in E14 rat cortical ventricular cells. Bottom panel: Arrow points to
expression and nuclear localization of P-SMAD1/5/8 in E16.5 mouse cortical ventricular
cells. (E) qPCR measurement of Bmps 2,4,5, and 7 in the E16, E18, P0, and adult rat
choroid plexus (CP). (F) Quantification of RA activity in E14, E17, and adult rat CSF. RA
activity declined, based on comparison of CSF activation of an RA responsive, clonally
derived cell line with response to RA at known concentrations, from mid-gestation through
adulthood (ANOVA, p=0.07; n=4). (G) RA responsive progenitor cells at the cortical
ventricular zone from an E16.5 DR5-RARE transgenic mouse (LaMantia et al., 1993). (H)
qPCR of Raldh1, 2, 3, and Adh10, in rat CP.
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